Loading clinical trials...
Loading clinical trials...
A Phase I Study of the CDK4/6 Inhibitor PD-0332991, 5-Fluorouracil, and Oxaliplatin in Patients With Advanced Solid Tumor Malignancies
Conditions
Interventions
PD-0332991
5-FU
+1 more
Locations
1
United States
Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States
Start Date
December 1, 2011
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
March 4, 2020
NCT06927297
NCT07299747
NCT05791474
Lead Sponsor
Georgetown University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions